Search Results

There are 16823 results for: content related to: Targeting the growth factors and angiogenesis pathways: Small molecules in solid tumors

  1. Outcomes in the management of adult soft tissue sarcomas

    Journal of Surgical Oncology

    Volume 110, Issue 5, October 1, 2014, Pages: 527–538, Jeffrey S. Kneisl, Michelle M. Coleman and Chandrajit P. Raut

    Article first published online : 25 JUN 2014, DOI: 10.1002/jso.23685

  2. Management of recurrent gastrointestinal stromal tumors

    Journal of Surgical Oncology

    Volume 104, Issue 8, 15 December 2011, Pages: 915–920, Joshua H. Winer and Chandrajit P. Raut

    Article first published online : 17 FEB 2011, DOI: 10.1002/jso.21890

  3. Treatment strategy of rectal gastrointestinal stromal tumor (GIST)

    Journal of Surgical Oncology

    Volume 109, Issue 7, June 1, 2014, Pages: 708–713, Heli Liu, Zhongshu Yan, Guoqing Liao and Hongling Yin

    Article first published online : 10 FEB 2014, DOI: 10.1002/jso.23562

  4. Metastasectomy for gastrointestinal stromal tumors

    Journal of Surgical Oncology

    Volume 109, Issue 1, January 1, 2014, Pages: 23–27, Zubin M. Bamboat and Ronald P. DeMatteo

    Article first published online : 24 OCT 2013, DOI: 10.1002/jso.23451

  5. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Article first published online : 10 OCT 2014, DOI: 10.1002/jps.24113

  6. Sorafenib induces growth inhibition and apoptosis of human chondrosarcoma cells by blocking the RAF/ERK/MEK pathway

    Journal of Surgical Oncology

    Volume 102, Issue 7, 1 December 2010, Pages: 821–826, Xinchang Lu, Xiaodong Tang, Wei Guo, Tingting Ren and Hui Zhao

    Article first published online : 1 SEP 2010, DOI: 10.1002/jso.21661

  7. A multicenter long-term study of imatinib treatment for Japanese patients with unresectable or recurrent gastrointestinal stromal tumors

    Journal of Surgical Oncology

    Volume 110, Issue 8, December 15, 2014, Pages: 942–946, Kyoichi Ogata, Erito Mochiki, Hitoshi Ojima, Norihiro Haga, Minoru Fukuchi, Ryuusuke Aihara, Hiroyuki Ando, Nobuyuki Uchida, Yoshitaka Toyomasu, Masaki Suzuki, Akiharu Kimura, Norimichi Kogure, Takehiko Yokobori, Tetsuro Ohno and Hiroyuki Kuwano

    Article first published online : 27 AUG 2014, DOI: 10.1002/jso.23773

  8. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal

    Journal of Surgical Oncology

    Volume 107, Issue 4, 15 March 2013, Pages: 422–427, Quanrongzi Wang, Tongfu Yu, Yifeng Yuan, Haiwen Zhuang, Zhaojing Wang, Xisheng Liu and Min Feng

    Article first published online : 25 JUL 2012, DOI: 10.1002/jso.23227

  9. Implementation of modern therapy approaches and research for non-small cell lung cancer in Japan

    Respirology

    Volume 20, Issue 2, February 2015, Pages: 199–208, Yoichi Nakanishi

    Article first published online : 16 JAN 2015, DOI: 10.1111/resp.12460

  10. Src activity is increased in gastrointestinal stromal tumors—Analysis of associations with clinical and other molecular tumor characteristics

    Journal of Surgical Oncology

    Volume 109, Issue 6, May 1, 2014, Pages: 597–605, Julia Valerie Rotert, Jörg Leupold, Peter Hohenberger, Kai Nowak and Heike Allgayer

    Article first published online : 4 JAN 2014, DOI: 10.1002/jso.23544

  11. Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry

    Biomedical Chromatography

    Volume 27, Issue 4, April 2013, Pages: 466–476, N. A. G. Lankheet, M. J. X. Hillebrand, H. Rosing, J. H. M. Schellens, J. H. Beijnen and A. D. R. Huitema

    Article first published online : 17 SEP 2012, DOI: 10.1002/bmc.2814

  12. Antiangiogenic Therapy for Cancer: An Update

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 12, December 2012, Pages: 1095–1111, Belal Al-Husein, Maha Abdalla, Morgan Trepte, David L. DeRemer and Payaningal R. Somanath

    Article first published online : 3 DEC 2012, DOI: 10.1002/phar.1147

  13. Gastrointestinal stromal tumors: Current management

    Journal of Surgical Oncology

    Volume 102, Issue 5, 1 October 2010, Pages: 530–538, Peter W.T. Pisters and Shreyaskumar R. Patel

    Article first published online : 8 JAN 2010, DOI: 10.1002/jso.21460

  14. You have free access to this content
    Chronic myeloid leukemia 2011: Successes, challenges, and strategies—Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop

    American Journal of Hematology

    Volume 86, Issue 9, September 2011, Pages: 811–819, Tariq I. Mughal, Jerald P. Radich, Richard A. Van Etten, Alfonso Quintás-Cardama, Tomasz Skorski, Farhad Ravandi, Daniel J. DeAngelo, Carlo Gambacorti-Passerini, Giovanni Martinelli and Ayalew Tefferi

    Article first published online : 17 AUG 2011, DOI: 10.1002/ajh.22097

  15. Lessons learned from adult clinical experience to inform evaluations of VEGF pathway inhibitors in children with cancer

    Pediatric Blood & Cancer

    Volume 61, Issue 8, August 2014, Pages: 1497–1505, Malcolm A. Smith

    Article first published online : 24 APR 2014, DOI: 10.1002/pbc.25036

  16. Judging pathological assessment in cancer specimens

    Journal of Surgical Oncology

    Volume 110, Issue 5, October 1, 2014, Pages: 543–550, Mariana Berho and Pablo A. Bejarano

    Article first published online : 13 AUG 2014, DOI: 10.1002/jso.23738

  17. Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension

    Journal of Surgical Oncology

    Volume 110, Issue 2, August 1, 2014, Pages: 99–106, Mong-Wei Lin, Chen-Tu Wu, Jin-Yuan Shih, Yih-Leong Chang and Pan-Chyr Yang

    Article first published online : 30 APR 2014, DOI: 10.1002/jso.23628

  18. You have free access to this content
    Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

    British Journal of Pharmacology

    Volume 158, Issue 4, October 2009, Pages: 1153–1164, C Hegedűs, C Özvegy-Laczka, Á Apáti, M Magócsi, K Német, L Őrfi, G Kéri, M Katona, Z Takáts, A Váradi, G Szakács and B Sarkadi

    Article first published online : 28 SEP 2009, DOI: 10.1111/j.1476-5381.2009.00383.x

  19. Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells

    Molecular Carcinogenesis

    Yongik Lee, Yian Wang, Michael James, Joseph H. Jeong and Ming You

    Article first published online : 4 JUN 2015, DOI: 10.1002/mc.22342

  20. You have free access to this content
    Risk of venous thromboembolic events associated with VEGFR-TKIs: A systematic review and meta-analysis

    International Journal of Cancer

    Volume 132, Issue 12, 15 June 2013, Pages: 2967–2974, Wei-Xiang Qi, Da-Liu Min, Zan Shen, Yuan-Jue Sun, Feng Lin, Li-Na Tang, Ai-Na He and Yang Yao

    Article first published online : 27 DEC 2012, DOI: 10.1002/ijc.27979